Indiana Medical Scientist/Engineer Training Program
印第安纳州医学科学家/工程师培训计划
基本信息
- 批准号:9096193
- 负责人:
- 金额:$ 39.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Nationally, trends suggest that there are diminishing numbers of academic physician investigators. Thus, there is a need to train a cadre of future scientists who can link their research to clinical care to address the trends, causes, and treatment of disease. The Indiana University Medical Scientist/Engineer Training Program (MSTP) was conceived to meet this need, and this application represents the first competitive renewal of the Indiana MSTP since its funding almost 4 years ago. A unique and notable aspect of our program is the integration of faculty within the Weldon School of Biomedical Engineering at Purdue University to include the exceptional training of physician engineers. The aim of the Indiana Medical Scientist/Engineer Training Program is to provide interdisciplinary, integrated medical and scientific research training to develop students into engaging physician investigators who are poised to pursue careers in hypothesis-driven research that advances human health. With the support from a large, dedicated endowment to the program, the new PI of this application (Dr. R. Mirmira, himself a graduate of an MSTP) and his Co-Director (Dr. M. Harrington) have taken important and progressive steps to enhance physician scientist training, including the introduction of clinical experiences during graduate training, expansion of seminars/enrichment activities, and institution of formal internal and external feedback policies to implement programmatic changes. In close collaboration with the Weldon School of Biomedical Engineering at Purdue University, we have designed and implemented a flexible curriculum that provides in-depth training for students in a specific area of science and/or engineering relevant to human disease. Our program emphasizes coursework that broadens research training at the bench with quantitative skills, provides opportunities for public speaking provides a range of enriching extracurricular opportunities, and allows for integration of medicine and science/engineering throughout all years of training. Defined oversight mechanisms are in place to track the progress of trainees throughout the program. With the help of our outreach activities and the MSTP designation, our program notoriety has grown tremendously, as evidenced by a 400% increase in our applicant pool over the past 10 years and the remarkable diversity of our current student pool (23% underrepresented or with documented disabilities and 44% from out-of-state). In this competitive renewal application, we will build upon our successes and to make the necessary programmatic adjustments going forward to ensure that our trainees continue to be prepared to become future scientists and engineers who pioneer advances in medical practice through research.
描述(由申请人提供):在全国范围内,趋势表明,学术医师研究人员数量减少。因此,有必要培训一群未来科学家的干部,他们可以将研究与临床护理联系起来,以解决疾病的趋势,原因和治疗。印第安纳大学医学科学家/工程师培训计划(MSTP)被构想以满足这一需求,该申请是印第安纳州MSTP的首个竞争性续约,自大约4年前的资金以来。我们计划的一个独特而著名的方面是,在普渡大学的韦尔登生物医学工程学院内的教职员工融合,包括对医师工程师的特殊培训。印第安纳州医学科学家/工程师培训计划的目的是提供跨学科的,综合的医学和科学研究培训,使学生成为参与医师研究人员,他们准备从事假设驱动的研究,从而促进人类健康。 With the support from a large, dedicated endowment to the program, the new PI of this application (Dr. R. Mirmira, himself a graduate of an MSTP) and his Co-Director (Dr. M. Harrington) have taken important and progressive steps to enhance physician scientist training, including the introduction of clinical experiences during graduate training, expansion of seminars/enrichment activities, and institution of formal internal and external feedback policies to implement programmatic changes.在与普渡大学的Weldon生物医学工程学院密切合作,我们设计并实施了一种灵活的课程,为与人类疾病有关的特定科学和/或工程学领域的学生提供了深入的培训。我们的计划强调课程工作,该课程以定量技能在替补席上扩大研究培训,为公开演讲提供了机会,提供了一系列丰富的课外机会,并允许在所有年份的培训中整合医学和科学/工程学。有定义的监督机制可以追踪整个计划的学员的进步。在我们的外展活动和MSTP指定的帮助下,我们的计划的臭名昭著已大大增长,这证明了过去10年中申请人池增加400%,而当前学生池的显着多样性(23%的占代表性不足或有记录的残疾人,也有44%的人,而对状态不足)。在这项竞争性更新的应用中,我们将基于我们的成功,并进行必要的程序调整,以确保我们的受训者继续准备成为未来的科学家和工程师,他们通过研究提高了医学实践的进步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raghavendra G Mirmira其他文献
Raghavendra G Mirmira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Raghavendra G Mirmira', 18)}}的其他基金
The 12-HETE receptor Gpr31 in the -cell pathogenesis of type 1 diabetes
12-HETE 受体 Gpr31 在 1 型糖尿病细胞发病机制中的作用
- 批准号:
10047529 - 财政年份:2020
- 资助金额:
$ 39.78万 - 项目类别:
Validation of small molecule 12-lipoxygenase inhibitors in metabolic disease
小分子 12-脂氧合酶抑制剂在代谢疾病中的验证
- 批准号:
10130042 - 财政年份:2015
- 资助金额:
$ 39.78万 - 项目类别:
Chromatin Cofactors in Islet Development and Function
胰岛发育和功能中的染色质辅助因子
- 批准号:
8245180 - 财政年份:2010
- 资助金额:
$ 39.78万 - 项目类别:
Chromatin Cofactors in Islet Development and Function
胰岛发育和功能中的染色质辅助因子
- 批准号:
8443853 - 财政年份:2010
- 资助金额:
$ 39.78万 - 项目类别:
Chromatin Cofactors in Islet Development and Function
胰岛发育和功能中的染色质辅助因子
- 批准号:
7796288 - 财政年份:2010
- 资助金额:
$ 39.78万 - 项目类别:
Chromatin Cofactors in Islet Development and Function
胰岛发育和功能中的染色质辅助因子
- 批准号:
8053792 - 财政年份:2010
- 资助金额:
$ 39.78万 - 项目类别:
相似海外基金
Indiana Medical Scientist/Engineer Training Program
印第安纳州医学科学家/工程师培训计划
- 批准号:
10555556 - 财政年份:2023
- 资助金额:
$ 39.78万 - 项目类别:
Fluoroscopic drill attachment for orthopedic trauma surgery
用于骨科创伤手术的透视钻附件
- 批准号:
10819235 - 财政年份:2023
- 资助金额:
$ 39.78万 - 项目类别:
Indiana Clinical and Translational Sciences Institute
印第安纳临床与转化科学研究所
- 批准号:
10622172 - 财政年份:2023
- 资助金额:
$ 39.78万 - 项目类别:
Development of Optofluidic Resonators for Filoviral Detection
用于丝状病毒检测的光流控谐振器的开发
- 批准号:
10506889 - 财政年份:2022
- 资助金额:
$ 39.78万 - 项目类别:
Spatiotemporal and Deep Learning Analysis of Cardiac Imaging for Predictive Risk Stratification in Duchenne Muscular Dystrophy
心脏成像的时空和深度学习分析用于杜氏肌营养不良症的预测风险分层
- 批准号:
10536912 - 财政年份:2022
- 资助金额:
$ 39.78万 - 项目类别: